Literature DB >> 27895148

TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer.

Zhen Chen1, Chunlei Tang1, Yaodan Zhu1, Mingxu Xie1, Dongxu He2, Qiongxi Pan1, Peng Zhang1,3, Dong Hua4, Teng Wang4, Linfang Jin4, Xiaowei Qi4, Yifei Zhu1, Xiaoqiang Yao3, Jian Jin1, Xin Ma5.   

Abstract

Transient receptor potential channel 5 (TrpC5) is a member of the TrpC subgroup, and it forms a receptor-activated, non-selective Ca2+ channel. The architecture of the TrpC5 channel is poorly understood. In the present study, we report that TrpC5 is a key factor in regulating differentiation in colorectal cancer (CRC). Through a study of specimens from a large cohort of patients with CRC, we found that TrpC5 was highly expressed and its cellular level correlated with tumour grade. We showed further that up-regulated TrpC5 caused a robust rise in intracellular calcium concentration [Ca2+]i, increased Wnt5a expression and the nuclear translocation of β-catenin, leading to a reduction in cancer differentiation and an increase in cancer cell stemness. Notably, patients with tumours that expressed high levels of TrpC5 showed significantly poorer disease-free and overall survival. Therefore, our findings suggest that TrpC5 is an independent adverse prognostic factor for death in CRC, reducing differentiation through the Ca2+/Wnt5a signalling pathway.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Ca2+/Wnt5a signalling pathway; TrpC5 ion channel; cancer cell differentiation; colorectal cancer

Mesh:

Substances:

Year:  2016        PMID: 27895148     DOI: 10.1042/CS20160759

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.

Authors:  Yanli Wang; Chunling Xu; Yun Wang; Xiaomeng Zhang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 2.  Transient receptor potential (TRP) channels in human colorectal cancer: evidence and perspectives.

Authors:  Theodoros Rizopoulos; Martha Assimakopoulou
Journal:  Histol Histopathol       Date:  2021-02-02       Impact factor: 2.303

3.  Letter to the Editor: "Ion Channels in Brain Metastasis"-Ion Channels in Cancer Set up and Metastatic Progression.

Authors:  Daniela D'Arcangelo; Ezio M Nicodemi; Antonio Facchiano
Journal:  Int J Mol Sci       Date:  2017-03-28       Impact factor: 5.923

4.  Cancer-associated fibroblasts in gastric cancer affect malignant progression via the CXCL12-CXCR4 axis.

Authors:  Yan Qin; Fang Wang; Hengli Ni; Yao Liu; Yuan Yin; Xinyi Zhou; Guihua Gao; Qing Li; Xiaowei Qi; Jianming Li
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

Review 5.  Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.

Authors:  Hui Zhao; Tianqi Ming; Shun Tang; Shan Ren; Han Yang; Maolun Liu; Qiu Tao; Haibo Xu
Journal:  Mol Cancer       Date:  2022-07-14       Impact factor: 41.444

Review 6.  Roles of calcium signaling in cancer metastasis to bone.

Authors:  Tianying Xie; Sitong Chen; Jiang Hao; Pengfei Wu; Xuelian Gu; Haifeng Wei; Zhenxi Li; Jianru Xiao
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

7.  MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A.

Authors:  Meiyue Liu; Yue Zhang; Jie Zhang; Haifeng Cai; Chao Zhang; Zhao Yang; Yi Niu; Huan Wang; Xiaomei Wei; Wei Wang; Peng Gao; Hongmin Li; Jinghua Zhang; Guogui Sun
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

8.  TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.

Authors:  Jiangxia Fan; Yan Zhang; Junhao Mu; Xiaoqian He; Bianfei Shao; Dishu Zhou; Weiyan Peng; Jun Tang; Yu Jiang; Guosheng Ren; Tingxiu Xiang
Journal:  Clin Epigenetics       Date:  2018-08-03       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.